Longevity & Anti-Aging Peptides
Research peptides targeting the hallmarks of biological aging: mitochondrial function, NAD+ metabolism, telomere maintenance, thymic regeneration and circadian bioregulation. Our category features the Khavinson school (Epitalon and related tetrapeptides), mitochondrially encoded peptides such as MOTS-c and SS-31, the copper tripeptide GHK-Cu, and NAD+ boosters. These compounds sit at the cutting edge of preclinical longevity research in 2026. Every batch is independently HPLC-tested for identity and purity by Janoshik Analytical, and the certificates of analysis are available per batch on each product page.
All products
Related research
May 15, 2026
Epitalon protocol: typical cycles and research doses from the Khavinson literature
Overview of Epitalon research protocols: typical cycle durations, dose ranges from the Khavinson school, stability, and limitations of the current evidence base.
Read more →
April 17, 2026
MOTS-c and Muscle: The 2024 CK2α Mechanism Breakthrough
Lu et al. 2024 in iScience: MOTS-c binds directly to Casein Kinase 2 alpha (CK2α) in skeletal muscle. The mechanism that explains the exercise link.
Read more →
April 17, 2026
FDA Approves FORZINITY (Elamipretide / SS-31): The First Mitochondria-Targeted Drug in History
19 September 2025: FDA granted accelerated approval to FORZINITY (elamipretide, SS-31) for Barth syndrome. Analysis of TAZPOWER, ReCLAIM-2.
Read more →





